Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIII

Anti-drug antibodies to coagulation factor VIII (fVIII), often termed inhibitors, present the greatest economical and treatment related obstacle in the management of hemophilia A. Although several genetic and environmental risk factors associated with inhibitor development have been identified, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakas, Philip M., Healey, John F., Smith, Ian W., Lillicrap, David, Lollar, Pete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020254/
https://www.ncbi.nlm.nih.gov/pubmed/32117290
http://dx.doi.org/10.3389/fimmu.2020.00150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020254/
https://www.ncbi.nlm.nih.gov/pubmed/32117290
http://dx.doi.org/10.3389/fimmu.2020.00150

Ejemplares similares